Your account is not claimed yet. You can sign up with ORCID to claim your account.

Thomas Berg (Mark Danta, M Danta)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

Alimentary pharmacology & therapeutics

Journal of gastroenterology and hepatology

Hepatology communications

Neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Joga Chaganti, Georgia Zeng, Nway Tun, Ian Lockart, Christina Abdel Shaheed, Lucette Cysique, Sara Montagnese, Bruce J Brew, Thomas Berg
Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE. Hepatology communications 7 (4) (2023)
Joga Chaganti, Georgia Zeng, Nway Tun, Ian Lockart, Christina Abdel Shaheed, Lucette Cysique, Sara Montagnese, Bruce J Brew, Thomas Berg
Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE. Hepatology communications 7 (4) (2023)
Yuen Kang Joseph Yeoh, Gregory J Dore, Ian Lockart, Thomas Berg, Ciara Flynn, Conner Blackmore, Miriam Tania Levy, Jacob George, Maryam Alavi, Behzad Hajarizadeh
Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia. Internal medicine journal (2023)
Joga Chaganti, Georgia Zeng, Nway Tun, Ian Lockart, Christina Abdel Shaheed, Lucette Cysique, Sara Montagnese, Bruce J Brew, Thomas Berg
Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE. Hepatology communications 7 (4) (2023)
Ian Lockart, Malcolm G H Yeo, Behzad Hajarizadeh, Gregory J Dore, Thomas Berg
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis. Hepatology (Baltimore, Md.) 76 (1) (2022)
David Stephen Prince, Glen Schlaphoff, Scott Anthony Davison, Ya Ruth Huo, Hao Xiang, Michael Vinchill Chan, Alice Unah Lee, Cynthuja Thailakanathan, Hazem Jebeili, Christopher Rogan, Ahmed Al-Omary, Sidhartha Gupta, Ian Lockart, Neha Tiwari, McCawley Clark-Dickson, James William Hillhouse, Robyn Laube, Jeff Chang, Vi Nguyen, Thomas Berg, Robert Cheng, Simone Irene Strasser, Amany Zekry, Miriam Tania Levy, Christine Chan, Ken Liu
Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study. Journal of gastroenterology and hepatology 37 (11) (2022)
Ian Lockart, Behzad Hajarizadeh, Niamh Buckley, Scott Davison, Emilia Prakoso, Miriam T Levy, Jacob George, Gregory J Dore, Thomas Berg
All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy. Journal of gastroenterology and hepatology (2021)
Rachael Jacob, Thomas Berg
Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfection. Expert opinion on pharmacotherapy 23 (4) (2021)
Thomas Berg, Regina Zi Hwei Tan, Ian Lockart, Christina Abdel Shaheed
Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply. Alimentary pharmacology & therapeutics 54 (6) (2021)
Regina Zi Hwei Tan, Ian Lockart, Christina Abdel Shaheed, Thomas Berg
Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma. Alimentary pharmacology & therapeutics 54 (4) (2021)
Felicity C Smith, Sophie L Stocker, Thomas Berg, Jane E Carland, Shaun S Kumar, Zhixin Liu, Jerry R Greenfield, Hannah E Braithwaite, Tim S Cheng, Garry G Graham, Kenneth M Williams, Richard Osborne Day
The safety and pharmacokinetics of metformin in patients with chronic liver disease. Alimentary pharmacology & therapeutics 51 (5) (2020)
Georgia Zeng, Ross Penninkilampi, Joga Chaganti, Sara Montagnese, Bruce J Brew, Thomas Berg
Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy. Neurology 94 (11) (2020)
Thomas Berg, Georgia Zeng, Sara Montagnese
Author response: Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy. Neurology 95 (21) (2020)
S Sanagapalli, Thomas Berg
Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection. Alimentary pharmacology & therapeutics 47 (4) (2019)
Nan Phyu Sin Toe Myint, Thet Tun Zaw, Kyauk Sain, Soe Waiyan, Thomas Berg, David Cooper, Ne Myo Aung, Mar Mar Kyi, Josh Hanson
Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability. Journal of gastroenterology and hepatology 35 (4) (2019)
Sichan He, Ian Lockart, Maryam Alavi, Thomas Berg, Behzad Hajarizadeh, Gregory J Dore
Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma. Alimentary pharmacology & therapeutics 51 (1) (2019)
Thomas Berg, Uwe Naumann, Albrecht Stoehr, Christoph Sick, Christine John, Gerlinde Teuber, Willibold Schiffelholz, Stefan Mauss, Kristina Lohmann, Bettina König, Andreas Pangerl, Claus Niederau
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C-Registry. Alimentary pharmacology & therapeutics 49 (8) (2019)
Thomas Berg, D A Barber, H P Zhang, M Lee-Ng, S W L Baumgart, V W W Tsai, Y Husaini, M Saxena, Christopher P Marquis, W Errington, S Kerr, S N Breit, D A Brown
Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia. Alimentary pharmacology & therapeutics 46 (3) (2017)

Thomas Berg.css-eqlu8i{font-size:small;padding-left:4px;} (Mark Danta, M Danta)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Berg (Mark Danta, M Danta)